Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harte Hanks (HHS) Invested Capital (2016 - 2025)

Harte Hanks has reported Invested Capital over the past 16 years, most recently at $21.2 million for Q4 2025.

  • Quarterly Invested Capital fell 5.87% to $21.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.2 million through Dec 2025, down 5.87% year-over-year, with the annual reading at $21.2 million for FY2025, 5.87% down from the prior year.
  • Invested Capital was $21.2 million for Q4 2025 at Harte Hanks, up from $20.5 million in the prior quarter.
  • Over five years, Invested Capital peaked at $22.9 million in Q2 2025 and troughed at -$53.9 million in Q1 2021.
  • The 5-year median for Invested Capital is $20.3 million (2023), against an average of $5.4 million.
  • Year-over-year, Invested Capital fell 21.7% in 2021 and then surged 366.5% in 2023.
  • A 5-year view of Invested Capital shows it stood at -$19.7 million in 2021, then surged by 195.4% to $18.8 million in 2022, then increased by 5.82% to $19.9 million in 2023, then increased by 12.91% to $22.5 million in 2024, then decreased by 5.87% to $21.2 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Invested Capital are $21.2 million (Q4 2025), $20.5 million (Q3 2025), and $22.9 million (Q2 2025).